From Yahoo Finance: 2025-04-09 12:32:00

Share prices in major medtech companies continued to decrease due to ongoing fallout from Trump’s trade war. China implemented an 84% tariff on US imports, affecting the second largest medtech market. AdvaMed warns that blanket tariffs will harm US medical technology and innovation. GE HealthCare faces challenges due to Chinese anti-dumping investigation. Some companies like Abbott and Dexcom may outperform in the current environment.



Read more at Yahoo Finance: Medtech stocks continue to slide as China hits back at Trump tariffs